Swiss National Bank’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Sell |
82,200
-700
| -0.8% | -$22.1K | ﹤0.01% | 1640 |
|
|
2025
Q1 | $2.75M | Buy |
82,900
+4,700
| +6% | +$156K | ﹤0.01% | 1583 |
|
|
2024
Q4 | $2.69M | Buy |
78,200
+17,200
| +28% | +$592K | ﹤0.01% | 1686 |
|
|
2024
Q3 | $2.44M | Sell |
61,000
-500
| -0.8% | -$20K | ﹤0.01% | 1745 |
|
|
2024
Q2 | $1.86M | Sell |
61,500
-2,100
| -3% | -$63.4K | ﹤0.01% | 1855 |
|
|
2024
Q1 | $2.14M | Sell |
63,600
-1,500
| -2% | -$50.4K | ﹤0.01% | 1802 |
|
|
2023
Q4 | $2.1M | Sell |
65,100
-14,000
| -18% | -$452K | ﹤0.01% | 1798 |
|
|
2023
Q3 | $2.59M | Buy |
79,100
+7,300
| +10% | +$239K | ﹤0.01% | 1678 |
|
|
2023
Q2 | $2.53M | Buy |
71,800
+20,600
| +40% | +$725K | ﹤0.01% | 1739 |
|
|
2023
Q1 | $1.67M | Sell |
51,200
-5,900
| -10% | -$193K | ﹤0.01% | 1949 |
|
|
2022
Q4 | $3.15M | Buy |
57,100
+1,100
| +2% | +$60.6K | ﹤0.01% | 1603 |
|
|
2022
Q3 | $2.48M | Buy |
56,000
+900
| +2% | +$39.9K | ﹤0.01% | 1722 |
|
|
2022
Q2 | $2.69M | Buy |
55,100
+13,600
| +33% | +$663K | ﹤0.01% | 1711 |
|
|
2022
Q1 | $2.02M | Buy |
41,500
+3,900
| +10% | +$190K | ﹤0.01% | 2039 |
|
|
2021
Q4 | $1.6M | Hold |
37,600
| – | – | ﹤0.01% | 2202 |
|
|
2021
Q3 | $1.44M | Hold |
37,600
| – | – | ﹤0.01% | 2242 |
|
|
2021
Q2 | $1.06M | Buy |
+37,600
| New | +$1.06M | ﹤0.01% | 2455 |
|